Cytomegalovirus-associated esophageal ulcer in an immunocompetent infant: When should ganciclovir be administered?.
10.3345/kjp.2012.55.12.491
- Author:
Hyo Jeong JANG
1
;
Ae Suk KIM
;
Jin Bok HWANG
Author Information
1. Department of Pediatrics, Keimyung University School of Medicine, Daegu, Korea. pedgi@kmu.ac.kr
- Publication Type:Case Report
- Keywords:
Cytomegalovirus;
Esophageal ulcer;
Ganciclovir
- MeSH:
Biopsy;
Cytomegalovirus;
Endoscopy, Digestive System;
Esophagus;
Female;
Follow-Up Studies;
Ganciclovir;
Humans;
Inclusion Bodies;
Infant;
Ulcer;
Viruses;
Vomiting
- From:Korean Journal of Pediatrics
2012;55(12):491-493
- CountryRepublic of Korea
- Language:English
-
Abstract:
Cytomegalovirus (CMV)-associated esophageal ulcer is rare in immunocompetent infants. The presence of inclusion bodies and immunohistochemical staining for CMV in biopsy specimens obtained during esophagogastroduodenoscopy (EGD) indicate that such ulcers occur because of CMV infection. A 7-week-old female infant who experienced frequent vomiting and feeding intolerance was diagnosed with a massive CMV-associated ulcer in the distal esophagus. The ulcer improved after conservative treatment using proton-pump inhibitors; however, ganciclovir was not administered. In a follow-up EGD biopsy specimen, no CMV inclusion bodies were present, and immunohistochemical staining results for this virus were negative. The presence of CMV inclusion bodies indicates active viral replication. If persistent inclusion bodies or positive immunohistochemical staining for CMV is observed in follow-up biopsy specimens, ganciclovir may be used to treat CMV-associated esophageal ulcers.
